ERT involves the administration of recombinant enzymes that are either identical or functionally similar to the missing or defective enzymes. These enzymes are typically produced using recombinant DNA technology, which allows for the mass production of human enzymes in microbial or mammalian cell cultures. Once administered, these enzymes are taken up by the cells and start catalyzing the necessary biochemical reactions.
